F. Akyuz Et Al. , "Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period," JOURNAL OF CROHNS & COLITIS , vol.14, 2020
Akyuz, F. Et Al. 2020. Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period. JOURNAL OF CROHNS & COLITIS , vol.14 .
Akyuz, F., Ormeci, A., Namazova, N., Guzel, M., Abbasgoulizadeh, A., Tahincioglu, L., ... Alaskarli, S.(2020). Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period. JOURNAL OF CROHNS & COLITIS , vol.14.
Akyuz, F. Et Al. "Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period," JOURNAL OF CROHNS & COLITIS , vol.14, 2020
Akyuz, F. Et Al. "Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period." JOURNAL OF CROHNS & COLITIS , vol.14, 2020
Akyuz, F. Et Al. (2020) . "Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period." JOURNAL OF CROHNS & COLITIS , vol.14.
@article{article, author={F. Akyuz Et Al. }, title={Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period}, journal={JOURNAL OF CROHNS & COLITIS}, year=2020}